Testis size and sperm production are directly correlated to the total number of adult Sertoli cells (SCs). Although the establishment of an adequate number of SCs is crucial for future male fertility, the identification and characterization of the factors regulating SC survival, proliferation, and maturation remain incomplete. To investigate whether the IGF system is required for germ cell (GC) and SC development and function, we inactivated the insulin receptor (Insr), the IGF1 receptor (Igf1r), or both receptors specifically in the GC lineage or in SCs. Whereas ablation of insulin/IGF signaling appears dispensable for GCs and spermatogenesis, adult testes of mice lacking both Insr and Igf1r in SCs (SC-Insr;Igf1r) displayed a 75% reduction in testis size and daily sperm production as a result of a reduced proliferation rate of immature SCs during the late fetal and early neonatal testicular period. In addition, in vivo analyses revealed that FSH requires the insulin/IGF signaling pathway to mediate its proliferative effects on immature SCs. Collectively, these results emphasize the essential role played by growth factors of the insulin family in regulating the final number of SCs, testis size, and daily sperm output. They also indicate that the insulin/IGF signaling pathway is required for FSH-mediated SC proliferation. (Molecular Endocrinology 27: 814 -827, 2013) S permatogenesis refers to a complex differentiation process by which diploid spermatogonial stem cells develop into mature haploid spermatozoa. In the adult, Sertoli cells (SCs), the only somatic constituents of the seminiferous epithelium, are in direct physical association with all types of germ cells (GCs) and are mainly commit-
ted to sustain spermatogenesis. In particular, SCs provide GCs with a structural support and a preserved environment with the blood-testis barrier, assist their movement toward the seminiferous epithelium lumen and sustain their development through their secretory products (for reviews, see Refs. 1 and 2). Notably, individual SCs can only support a finite number of GCs. Therefore, the final testis size, the number of GCs in the adult testis, and sperm output are directly linked to the total number of SCs (3) . It has been well established that the SC proliferation window in mice occurs during late fetal and early neonatal testicular development and the final adult number is reached by postnatal day (P) 15 (4, 5) . This creates a stable, nondividing SC population that matures and progressively acquires the ability to sustain GC development (reviewed in Refs. 1 and 6) .
Deciphering the factors that regulate the establishment of an adequate population of mature SCs and thus testis size remains one of the most critical questions in testicular biology. FSH is considered one of the major endocrine hormones regulating SC proliferation, with no synergistic or additive effect from androgens (3, 4, 7, 8) . The influence of several other paracrine factors and systemic hormones (eg, thyroid hormones) in this process has also been described (9 -16) .
Insulin and its related growth factors IGF1 and IGF2 can modulate a variety of cellular activities including cell survival, stimulation of cell proliferation, differentiation, and metabolism (17, 18) . The physiological effects of these factors are mediated through activation of 2 tyrosine kinase receptors: the insulin receptor (INSR) and the type I insulin-like growth factor receptor (IGF1R). Insulin and IGF1 bind primarily to INSR and IGF1R, respectively, whereas IGF2 binds, with somewhat similar affinities, to both receptors (19 -21) . Upon activation, INSR and IGF1R phosphorylate common substrates that activate a network of downstream effectors, including the phosphatidylinositol 3-kinase (PI3K) and the mitogenactivated protein kinase (MAPK) pathways, which are both associated with proliferation, differentiation, and cell survival (22, 23) .
Several reports have shown that IGF1 regulates important testicular functions such as testosterone production by Leydig cells (LCs) (24) . Unfortunately, little is known about the local actions that the insulin-like family of growth factors exert on GCs and SCs in vivo, because the constitutive invalidation of their cognate receptors systematically leads to perinatal lethality. To overcome these difficulties, we took advantage of the site specific Cre-lox recombination system to delete Insr and/or Igf1r specifically in SCs or the GC lineage during testicular development. By this means, we were able to demonstrate that the insulin/IGF growth factor family is an essential component of the endocrine and paracrine network that regulates testis growth and sperm production in mammals.
Materials and Methods

Animals
Insr flox (Insr fx/fx ), Igf1r flox (Igf1r fx/fx ), and MisCre (Amh: Cre) mice were provided by R. Kahn (Boston, Massachusetts), A. Efstratiadis (New York, New York), and F. Guillou (Tours, France), respectively, and were genotyped at weaning (P21) from tail biopsies by classic PCR as described previously (25) (26) (27) (28) . Both GC-specific Cre transgenic lines were genotyped by classic PCR using either Cre-recombinase-specific primers for the Ngn3:Cre transgene (20973, 5Ј-CCTGTTTTGCACGTTCACCG-3Ј; 20974, 5Ј-ATGCTTCTGTCCGTTTGCCG-3Ј) or a set of primers specific for the Mvh;Cre transgene as described previously (28) . Animals were housed and cared for according to the ethical guidelines of the Direction Générale de la Santé of the Canton de Genève (experimentation ID: 1061/3430/1).
Fertility tests and sperm analysis
Mice lacking mice lacking Insr, Igf1r, and both in SCs (SCInsr, SC-Igf1r, and SC-Insr;Igf1r, respectively) (n ϭ 3-4) or control Insr fxfx ;Igf1r fxfx males were each bred with 2 6-weekold wild-type C57BL/6 female mice for a period of 6 months. Number of litters and pups per litter were systematically recorded. The epididymal sperm count was performed with sperm extracted from the caudal epididymis and ductus deferens of adult (P180) male mice and was analyzed for its concentration and viability as described previously (29 -31) . The testicular sperm count was evaluated from testis by enumeration of homogenization-resistant spermatid and spermatozoa nuclei using phase-contrast microscopy as described previously (32) . In short, adult testis (P180) from 6 controls and 6 SC-Insr;Igf1r double-mutant mice were decapsulated and homogenized in a blender for 45 seconds in 6 and 3 mL of H 2 O, respectively. After 2 rounds of sonication (12 kHz), an aliquot of the cell suspension was loaded on a Malassez hemocytometer and counted in duplicate.
Sperm motility
For each individual mouse, epididymal sperm were diluted in 1 mL of M2 medium just before analysis. Then 5 l of the sperm suspension was deposited in a 20-m-deep counting chamber (Leja Products, Nieuw-Vennep, The Netherlands) and submitted to computer-assisted sperm analysis (CASA) (SCA system; Microptic SL, Barcelona, Spain). Five to 10 video sequences were recorded (25 frames/s) at 37°C using a negative phasecontrast ϫ10 objective. The sperm motility parameters examined in this study were curvilinear velocity (VCL; micrometers per second), straight-line velocity (VSL; micrometers per second), average path velocity (VAP; micrometers per second), amplitude of lateral head displacement (ALH; micrometers), beatcross frequency (BCF; Hertz), linearity (LIN ϭ VSL/VCL; percent), straightness (STR ϭ VSL/VAP; percent), and wobble (WOB ϭ VAP/VCL; percent). Motility was categorized as nonprogressive (VAP Ͻ 15 m/s), slow progressive (VAP Ͼ 15 Ͻ 45 m/s), or fast progressive (VAP Ͼ 45 m/s), as indicated by the manufacturer's instructions. The number of sperm present in the initial 1-mL suspension was calculated by the CASA system (10 6 sperm cells/mL).
Histology and immunohistochemistry (IHC)
Testes and epididymides were fixed overnight either in 4% paraformaldehyde (PFA) or in Bouin fixative and embedded in paraffin. Sections (5-m) were stained with hematoxylin and eosin (H&E) or processed for IHC. For IHC analysis, PFA-fixed sections were incubated overnight at 4°C with the following antibodies: anti-INSR (1:100, sc-711; Santa Cruz Biotechnology, Santa Cruz, California), anti-IGF1R (1:50, sc-712; Santa Cruz Biotechnology); anti-GATA4 (1:50, sc-9053; Santa-Cruz Biotechnology), anti-p27 Kip1 (1:100, K0082-3S; MBL, Nagoya, Japan), anti-ZO1 (1:250, 61-7300; Zymed, South San , antismooth muscle actin (SMA) (1:100; gift from C. Chaponnier, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland), anti-␤ galactosidase (1:500, ab9361; Abcam, Cambridge, Massachusetts), anti-MVH (1: 1000; gift from Toshiaki Noce, Mitsubishi Kagaku of Life Sciences, Tokyo, Japan), and anti-3␤-hydroxysteroid dehydrogenase (HSD) (1:500; gift from Ian Mason, Queen Margaret University, Edinburg, United Kingdom). For fluorescent staining, Alexa-conjugated secondary antibodies (Invitrogen, Carlsbad, California) were used for signal revelations, whereas for stable staining, signals were revealed with 3,3Ј-diaminobenzidine (Sigma-Aldrich, Buchs, St-callen, Switzerland). All images were obtained with a Axioskop microscope (Carl Zeiss, Jena Germany) and processed using AxioVision software.
Proliferation and apoptosis assays
The proliferation assay was performed with PFA-fixed sections double stained with either anti-GATA4 (1:50, sc-9053; Santa-Cruz Biotechnology) and anti-Ki-67 (1:100, no. 556003; BD Biosciences, San Jose, California) overnight at 4°C or anti-GATA4 combined with the Click-iT EdU cell proliferation assay (Invitrogen) as described previously (33) . A minimum of 3 different animals per genotype and developmental stage were analyzed. For each testis, between 3 and 5 sections distant from one another by at least 60 m were selected, and pictures of 5 different fields per section were taken. Values are expressed as the percentage of proliferating SCs counted in a given region. Apoptotic assays were performed by means of both a terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) reaction using an In Situ Cell Death Kit (Roche Applied Science, Indianapolis, Indiana) and double IHC using anti-cleaved caspase 3 (1:200, no. 9961L; Cell Signaling Technology) and anti-GCNA1 (1:50; gift from Dr G.C. Enders, University of Kansas Medical Center, Kansas City, Kansas) to reveal the identity of TUNEL-positive cells. The percentage of apoptotic, TUNEL-positive cells within the seminiferous epithelium was expressed as the average number of apoptotic cells within 20 seminiferous tubules.
Testis morphometry
Thirty transverse sections of seminiferous tubules from 3 different animals per genotype were randomly selected to measure small diameters. Diameters were measured in seminiferous tubule sections that were round or close to being round. Morphometric analysis was performed on a BX51 Olympus microscope, and the image was captured using a JVC video camera. Analysis was performed using the software package CAST Grid (version 2.4.1, The Computer Assisted Stereological Toolbox; Olympus, Tokyo, Japan). To obtain the volume density of seminiferous tubules, the total number of tubules (round or near round) was scored for each histological section, and an average area of tubule was measured from at least 25 randomly selected tubules. To obtain a more precise measure of testis volume, shrinkage areas were excluded from the testis surface. Because the specific gravity of testis tissue was considered to be 1.0, the seminiferous tubule volume is determined as the product of the volume density and testis weight. The total length of seminiferous tubules (meters) was obtained by dividing seminiferous tubule volume by the squared radius of the tubule times the value (34) .
DNA content analysis by flow cytometry
For DNA content analysis, control and mutant testes were dissected out, and GCs were isolated and stained with the intercalating agent propidium iodide (PI) as described previously (62) . In short, control and SC-Insr;Igf1r testes (n ϭ 5) at P180 were dissected out and decapsulated to release the seminiferous tubules. The latter were incubated in collagenase type IV (Sigma-Aldrich) at 37°C for up to 5 minutes under rapid agitation. Dispersed tubules were allowed to settle down and were washed twice with PBS without Ca 2ϩ and Mg 2ϩ (Sigma-Aldrich) to remove the LCs and the peritubular myoid cells. Washed tubules were then incubated for 5 minutes in 0.5% trypsin EDTA (Gibco; Invitrogen) and RQ1/DNase (1 g/L; Promega, Madison, Wisconsin) at 37°C under agitation. A cell suspension was obtained by pipetting gently several times before addition of 10 L of heat-inactivated fetal calf serum to block trypsin activity. To generate a single-cell suspension, PBS without Ca 2ϩ and Mg 2ϩ was added, and the preparation was filtered through a 40-m nylon cell strainer (BD Falcon; BD Biosciences Discovery Labware, Bedford, Massachusetts). For nuclear analysis, GCs were rinsed and resuspended in 1 mL of cold PI stain (10 mM Tris, pH 8.0, 1 mM NaCl, 0.1% NP40, 50 g/mL PI, and 10 g/mL RNase A), vortexed for 2 to 3 seconds, and incubated on ice for 10 minutes to both lyse the plasma membrane and stain nuclear DNA. DNA content was assessed using a FACSCalibur II (BD Biosciences). (36) . At relevant stages, control and SC-Insr;Igf1r male pups homozygous for Sox9:EGFP were killed (n ϭ 5-10). Green fluorescent protein (GFP)-positive testes were decapsulated and incubated for 10 minutes in 0.5% trypsin EDTA and RQ1/DNase (4 mg/ mL) at 37°C. To ensure complete cellular dissociation, an additive digestive step was performed by incubating the cell clusters in a solution/cocktail of collagenase (10 mg/mL), hyaluronidase (20 mg/mL), and DNase (4 mg/mL). To generate a single-cell suspension, PBS without Ca 2ϩ and Mg 2ϩ was added, and the preparation was filtered through a 40-m nylon cell strainer (BD Falcon; BD Biosciences Discovery Labware). GFP ϩ cells were sorted using a FACSVantage SE (BD Biosciences). For RNA extraction, GFP ϩ or GFP Ϫ cells were directly sorted in lysis buffer from an RNeasy kit and extracted using an RNeasy micro kit (Qiagen, Valencia, California), according to the manufacturer's protocol. RNA integrity and quantity were assessed using RNA 6000 picochips with a 2100 bioanalyzer (Agilent Technologies, Santa Clara, California).
Isolation of total RNAs and proteins from purified
Classic and quantitative (q) real-time PCR
Between 120 and 1 g of total RNAs was reverse-transcribed with an Omniscript RT kit (Qiagen), according to the manufacturer's instructions, and 1 ⁄20 of the cDNA template was used as template for each PCR reaction. For regular RT-PCR amplification, a classic 30-cycle program was used as described previously (37) . Real-time RT-PCR was performed on each sample in triplicate using an ABI 7900HT SDS system with Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, California). Data were analyzed using a comparative critical threshold (C T ) method with the amount of target gene normalized to the average of 3 endogenous control genes (cyclophilin B, tubulin ␣, and tubulin ␤). Normalized quantities were averaged for at least 3 replicates for each data point and are presented as the mean Ϯ SD. The highest normalized relative quantity was arbitrarily designated as a value of 1.0. Fold changes were calculated from the quotient of means of these normalized quantities and are reported as the mean Ϯ SEM. The primers used for classic and qRT-PCR are listed in Supplemental Table 1 published on The Endocrine Society's Journals Online web site at http://mend.endojournals.org.
Hemicastration, FSH injection, and 6-propyl-2-thiouracil (PTU) treatment
Newborn pups were either hemicastrated or sham-operated at birth under hypothermia-induced anesthesia (38) . A small incision in the inguinal region was made, and the left testis was removed (39) . Groups of control or hemicastrated pups were placed back with their mothers, and animals were killed at P60. For FSH treatment, newborn control and mutant pups were injected subcutaneously from birth (P0) to P10 with recombinant human FSH (Gonal-F; Merck Serono) dissolved in physiological solution (200 IU/kg in 0.9% NaCl) to induce SC proliferation as described previously (40) . Pups were subjected to transient postnatal hypothyroidism by adding 0.1% PTU (Sigma-Aldrich) to the drinking water between birth and P25 as described previously (13) . Then, pups were weaned, and tap water was given ad libitum thereafter to allow recovery to euthyroidism. Mice were killed at P60.
Human chorionic gonadotropin (hCG) stimulation and hormonal assay
To evaluate the basal and hCG-stimulated serum concentrations of testosterone, control and mutant animals were subjected to an ip injection of hCG (Chorulon, 15 IU/animal). Blood was collected from a retro-orbital sinus puncture before the injection to determine basal levels. Two hours later, by the time of killing, blood was collected by an intracardiac puncture. Sera were obtained by centrifugation (8000 rpm, 10 minutes) and conserved at Ϫ20°C until hormone assays were performed. FSH and LH levels were measured using an immunobeads Milliplex magnetic kit as recommended by the supplier (Millipore Corporation, Billerica, Massachusetts). Testosterone levels were evaluated by RIA using a Testosterone Double Antibody RIA Kit from MP Biomedicals (Solon, Ohio) and activin A using an Activin A Quantikine ELISA Kit from R&D Systems (Minneapolis, Minnesota).
Results
Expression profile of Insr and Igf1r and their ligands in SCs and male GCs
SCs provide a highly specialized environment crucial for spermatogonia renewal and GC progression into spermatogenesis. To determine in which cells IGFs might play a role in regulating testicular function, we analyzed by qRT-PCR the expression of the insulin-like family of growth factors and their receptors in purified GCs and SCs at P5. At this stage, seminiferous tubules are exclusively composed of proliferating, immature SCs (ϳ84%) and primitive type A spermatogonia (ϳ16%) (41) . Taking advantage of a Sox9-eGFP knock-in mouse line that specifically labels SCs (35), we used fluorescence-activated cell sorting to isolate GFP ϩ and GFP Ϫ cell fractions from P5 testes. Both qRT-PCR and immunofluorescence (IF) analyses confirmed that the GFP ϩ fraction was composed of highly purified SCs (95% purity), whereas the GFP Ϫ fraction was composed mostly of GCs (ϳ70%) and Leydig cells (ϳ30%) (Supplemental Figure 1 , A-C). We found that transcripts coding for the growth factors Igf1 and Igf2 were present at levels ϳ10-fold higher in the spermatogonia-enriched GFP Ϫ fraction than in the GFP ϩ fraction ( Figure 1A ). In contrast, transcripts for Insr and Igf1r were present at similar levels in immature SCs and spermatogonia-enriched fractions. These expression profiles were confirmed by a large-scale transcriptional anal-ysis from a highly enriched population of mouse mature SCs, mitotic spermatogonia, meiotic spermatocytes, and postmeiotic round spermatids (42) (Supplemental Figure  1D) . Overall, the robust expression of Igf1 and Igf2 in male GCs and the presence of transcripts coding for Insr, Igf1r , and the common effectors Irs1 and Irs2 in SCs and GCs suggest that the insulin-like family of growth factors exerts autocrine-paracrine actions within the seminiferous epithelium.
Massive reduction in SC number, testis size, and testicular sperm counts in mice lacking insulin/IGF signaling in developing SCs
To investigate the functional relevance of insulin/IGF signaling in both the GC and supporting cell lineages, we specifically deleted Insr (43), Igf1r (26), or both Insr and Igf1r either in the male germ line using a Ngn3:Cre transgenic line (44) or in SCs using an Amh:Cre transgene (27) . Despite the fact that the Ngn3:Cre transgene was able to completely eliminate Insr and Igf1r in the male germ line, mice with a GC-specific deletion of Insr, Igf1r, or both Insr and Igf1r were viable and fertile (Supplemental Figure 2) . All reproductive parameters were normal including typical testicular histology, testis size, and sperm production, indicating that the insulin/IGF signaling pathway is dispensable for differentiating male GCs throughout the meiotic and postmeiotic stages of spermatogenesis. We then examine the in vivo role of insulin/IGF signaling in SCs. For Figure 1B ). This residual expression correlated well with the levels of GC contamination found in these GFP ϩ fractions, suggesting that we achieved an efficient and specific ablation of both receptors in SCs. These results were confirmed by IF, showing that signals for both INSR and IGF1R were specifically absent in SCs of mutant testis at P5 ( Figure 1C ). SC-Insr, SC-Igf1r, and SC-Insr;Igf1r mutants were all viable, grew to adulthood normally, and appeared to have normal sexual behavior and normal internal and external genitalia compared with those for control littermates. At P180, testes lacking Insr, Igf1r, or both Insr and Igf1r in SCs displayed weight reductions of 13.6%, 34.6%, and 72.4%, respectively, compared with those of their control littermates (Figure 2 , A-D and I, and Supplemental Table  2 ). Histological analysis of mutant testes revealed no gross histological alteration of the seminiferous epithelium, with the presence of GCs at all stages of spermatogenesis and spermiogenesis (Figure 2, E-H Insr;Igf1r mutants were decreased by 38.85% and 58.71%, respectively, compared with those in control animals ( Figure 2J and Supplemental Table 3 ). When the focus was exclusively on the double SC-Insr;Igf1r mutants, testicular sperm concentration, a reflection of daily sperm production, was also drastically reduced by 79% ( Figure 2K ). At this stage, neither the seminiferous epithelium architecture, the seminiferous tubule diameter, nor the SC number per tubule section was affected (Supplemental Figure 3, A-F) . However, we observed a massive 75% reduction in tubule length (wt, 1.86 Ϯ 0.1 m; SCInsr;Igf1r, 0.42 Ϯ 0.17 m; P ϭ .0002) (Figure 2L ), correlating well with a 74.3% reduction in the total number of SCs in SC-Insr;Igf1r mutant testes ( Figure 2M ).
Although sperm output was drastically reduced, sperm viability ( Figure 2N ) and sperm motility behavior were normal in SC-Insr, SC-Igf1r, and double SC-Insr;Igf1r mutant animals as measured by CASA (Supplemental Table 4). Because a reduction in sperm concentration could affect male reproductive function, we mated SC-Insr, SCIgf1r, and double SC-Insr;Igf1r mutant males with 2 C57BL/6 female mice for a period of 6 months. Frequencies of parturition and litter size were not affected, indicating that loss of function of Insr, Igf1r, or both Insr;Igf1r in SCs does not impair reproductive ability despite oligospermia (Figure 2 , O and P). Taken together, these results demonstrate that the massive reductions in testis size, tubule length, and sperm output in mutant animals is a consequence of a proportional reduction in the number of SCs.
Reduced SC proliferation in SC-Insr;Igf1r mice during late fetal and early neonatal testicular development
The establishment of an adequate number of SCs in the adult testis depends on the duration of the proliferative phase and the rate of division. We took advantage of the , and SC-Insr;Igf1r display 13.6%, 34.6%, and 72.4% reductions, respectively, compared with those for wt (I). Similarly, epididymal sperm concentrations were decreased by more than 38% and 58%, respectively, in SC-Igf1r and SC-Insr;Igf1r mutant animals (J). Testicular sperm concentration, a reflect of daily sperm production, was reduced by 72.4% in SC-Insr;Igf1r animals (K). Similarly, total seminiferous tubule's lengths (L) and GFP ϩ SCs (M) were reduced by 75% in SC-Insr;Igf1r animals. In contrast, sperm viability assessed by ethidium monomer staining of the spermatozoa was not affected (N). A fertility assay performed with WT or SC-Insr, SC-Igf1r, and SC-Insr;Igf1r males mated with 2 C57BL/6 females over a period of 6 months (n ϭ 3/genotype) did not reveal any reproductive defects because the number of litters (O) and the average pups per litter (P) were not affected. Values are expressed as means Ϯ SEM. ns, not statistically significant; *P Ͻ .05 vs control; **P Ͻ .01 vs control; ***P Ͻ .001 vs control. Scale bar in H corresponds to 50 m.
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Sox9;EGFP knock-in allele described previously to evaluate the progression in testis weight and SC numbers in both wt and SC-Insr;Igf1r mutant testes during late fetal and early neonatal testicular development. Whereas the first abnormalities in terms of testis weight appeared at P5 ( Figure 3A ), we observed a progressive and cumulative reduction of SC number in mutant animals during the late fetal and early neonatal stages of development ( Figure   3B ). At E17.5, about 3 to 4 days after the onset of Amh; Cre transgene expression, we already noticed a 40% reduction in SC number. This deficit in SCs worsened at later stages, reaching 43% at P0, 60% at P5, 67% at P15, and finally 74.3% at P60 ( Figure 2M) . A more refined analysis revealed that the daily rate of increase in SC number was primarily affected around E17.5 (Ϫ54%) and during the P0 to P5 period (Ϫ38%) ( Figure 3C ). This Note the significant reduction in the SC proliferative index during the E15.5 to E17.5 and P0 to P5 periods. Double IF using the SC marker GATA4 (red) and the proliferative marker Ki-67staining (green) is shown in both control (E and F) and SC-Insr;Igf1r mice (G and H) at E17.5 (E and G) and P5 (F and H). Values are expressed as means Ϯ SEM. ns, not statistically significant; *P Ͻ .05 vs control; **P Ͻ .01 vs control; ***P Ͻ .001 vs control. Scale bar in H corresponds to 50 m. dramatic reduction in testis size and total SC numbers during the late fetal/neonatal period led us to the assumption that the balance between cell proliferation and death had been perturbed in SCs lacking the insulin/IGF signaling pathway. As evidenced by double anti-GATA4/antiKi-67 IHC, SC proliferation rates were indeed reduced at 2 specific stages of development: by 66% at E17.5 and by 8% at P5 in SC-Insr;Igf1r testes compared with control testes (Figure 3, D-H) . These results were confirmed by combining anti-GATA4 IF with the Click-iT EdU cell proliferation assay (Supplemental Figure 4) . In contrast, apoptosis in SCs was unaffected (data not shown). These findings suggest that the striking testis size reduction observed in SC-Insr;Igf1r mice is a direct consequence of a reduced proliferation rate of immature SCs during the late fetal and early neonatal testicular period.
Transient delay in SC maturation and desynchronization of spermatogenesis in seminiferous tubules of SC-Insr; Igf1r testes
At E17.5 (data not shown) and birth (P0), double mutant testes displayed normal organization of the seminiferous epithelium and were histologically indistinguishable from controls ( Figure 4 , A and E). The first histological abnormalities appeared at P5 with spermatogonia being mislocalized in a central position instead of lying against the basement membrane (arrows in Figure 4F) . We also observed 2-and 6-fold increases in the number of apoptotic GCs in P3 and P5 mutant testes compared with control testes (data not shown), correlating with the reduced number of SCs and the first histological abnormalities. At P10, we detected numerous pyknotic cells (white arrowheads) within testis cords and a hyperplasia of the interstitial tissue ( Figure 4G ). By P15, no lumen was observed in mutant seminiferous tubules, probably due to absence of seminiferous tubular fluid secretion (46) resulting from a delay in SC maturation (Figure 4H ). In addition, several aspects of SC morphology suggested that these cells had remained in an immature state, because the nucleus did not reach a normal peripheral localization and strongly differed from the triangular shape characteristic of this developmental stage (Figure 4, D and H) . We also observed vacuoles within tubules, a typical sign of GC sloughing. Delay in SC maturation was also investigated by immunohistochemical localization of protein markers associated with SC maturity such as p27, a marker of terminal differentiation, and Z01, a tight junction-associated protein essential for the blood-testis barrier (Figure 4 , Q-Z). At P21, the few lumen that appeared late within the tubules of SC-Insr;Igf1r testes displayed a smaller diameter than those found in control tubules ( Figure 4M ). However, spermatogenesis was normal in P21 mutant testes with the appearance of the first round spermatids. Finally, at P42, the first wave of GC meiosis was normally achieved in both control and double mutant testes, and all stages of differentiating GCs were present within the seminiferous tubules. Interestingly, we noticed that the seminiferous epithelium cycle is desynchronized in some SC-Insr;Igf1r seminiferous tubes, with individual sections having atypical GC associations containing step 1 round spermatids (black arrow) with step 8 elongated spermatids (white arrow) (Figure 4 , L-P). These kinds of discrepancies were not observed in P180 mutant testis, indicating a transitory alteration of GC differentiation (Supplemental Figure 5) . These data show that SC maturation is delayed in SCInsr;Igf1r testes, resulting in a desynchronized progression of GCs during the first wave of spermatogenesis.
Morphology and function of Leydig cells and peritubular myoid cells were not affected in SC-
Insr;Igf1r mutant testes
In addition to regulating spermatogenesis, SCs are also required to promote differentiation of both peritubular myoid cells (PMCs) and LCs (47) . To investigate to what extent the numbers of PMCs and LCs were affected in SC-Insr;Igf1r, we performed IF assays using specific markers for both cell types. Using an antibody for SMA, we found that PMCs were not affected in terms of morphology, number/tubule, and localization in mutant testis ( Figure 5A , B, and E). These results imply that the total number of PMCs present in the mutant testis is reduced to the proportion of the remaining SCs/seminiferous tubules. Using an anti-3␤HSD to evaluate LC population, we found that the proportion of LCs present in the interstitial compartment was slightly increased in mutant testes (68% vs 61% in control) ( Figure 5, C, D, and F) . LC function was also evaluated by assessing the plasma levels of testosterone before (basal) and 2 hours after an ip injection of hCG (stimulated level). Although androgen levels in the basal state were not significantly affected, increased testosterone production by hCG was not as high as that in control animals (3.03-fold in mutant vs 7.69-fold in control animals) ( Figure 5G ). Interestingly, LH and activin levels were not affected, whereas FSH levels were 2.5-fold higher in mutant animals than in control mice ( Figure 5, H-J) . Overall, these results show that total numbers of LCs and PMCs are reduced at levels proportional to the number of SCs present in mutant testes. However, LC endocrine function was not significantly affected because basal testosterone levels were were not affected in terms of morphology or number/tubule (E), whereas the density of LCs in the interstitial compartment shows a slight increase in mutant testes (68% vs 61% in wt) (F). Plasma levels of FSH, LH, activin, and testosterone were evaluated in both control and mutant individuals (G-J). Basal testosterone (G), activin (H), and LH (I) levels were not affected, whereas testosterone levels under hCG stimulation were increased by 7.7-and 3-fold in control and SC-Insr;Igf1r individuals (G). FSH levels are 2.5-fold higher in the serum of in SC-Insr;Igf1r mutant animals (J). Values are expressed as means Ϯ SEM. ns, not statistically significant; *P Ͻ .05 vs control; **P Ͻ .01 vs control; ***P Ͻ .001 vs control. Scale bars in B and D correspond to 50 m. DAPI, 4Ј,6Ј-diamidino-2-phenylindole.
comparable and high enough to sustain normal spermatogenesis in mutant individuals.
Insulin/IGF signaling acts independently of thyroid hormones but is essential for FSH-mediated SC proliferation
The establishment of an adequate number of SCs in the adult testis depends on the duration of the proliferative phase and the rate of division. In mice, SCs proliferate from E12.5 through P10 (13) , and both thyroid hormones and FSH are critical primary regulators of neonatal SC proliferation and functional maturation. The massive reduction in the total number of SCs in mutant testes (ie, 74%) raises the possibility that the insulin/IGF signaling pathway may be required either for T3 or FSH action on neonatal SC proliferation and maturation.
To study the potential interaction between T3 and the insulin/IGF signaling pathway, we induced transient hypothyroidism during early postnatal development by adding the goitrogen PTU (0.1%) to the water from birth to P25 either in wt or SC-Insr;Igf1r mutant males ( Figure  6 , A-C). In P60 wt animals exposed to PTU, the relative testis weight and testicular reserves were both substantially increased by 150% and 149%, respectively, as reported previously (13) . Interestingly, in SCInsr;Igf1r mutant mice, we observed a similar increase in relative testis weight and testicular sperm reserve after neonatal PTU treatment. This increase in testis weight and function was accompanied by a 154% increase in seminiferous tubule length, indicating that hypothyroidism increases SC number in the absence of the insulin/IGF signaling pathway. These findings reveal that T3 and insulin/IGFs act independently to modulate the number of SCs through different pathways and mechanisms.
In parallel, we used a model of neonatal hemicastration (38) to investigate the potential interaction between FSH and the insulin/IGF signaling pathway. Neonatal removal of a single gonad results in a significant increase in serum FSH concentration and a subsequent increase in the number of SCs as well as the size and the sperm production from the remaining testis (38, 39) . Whereas testis size and epididymal sperm counts were increased by 142% and 134%, respectively, in hemicas- Figure 6, D-F) . To confirm the key role played by the insulin/IGF signaling pathway in mediating FSH proliferative action on immature SCs, we treated newborn control and SC-Insr;Igf1r mutant mice between birth (P0) and P10 with recombinant human FSH at a concentration known to promote SC proliferation and testicular growth in rats (40) . As expected, we found that testis size was significantly increased by 20% and 40% in control animals at P21 and P60, respectively. At P60, sperm output was also increased by 43% in controls ( Figure 6H ). In contrast, neither testis weight nor epididymal sperm counts were affected by FSH treatment in SC-Insr;Igf1r mutants compared with those in controls ( Figure 6 , G and H). Overall, these results indicate unambiguously that neonatal action of FSH requires the insulin/IGF signaling pathway to mediate its proliferative effects on immature SCs.
Both Fshr gene expression profile and AKT activation were affected in SCs lacking tINSR and IGF1R
In mutant animals, high FSH levels ( Figure 5J ) coupled with the inability to respond to FSH (Figure 6 , D-H) suggest that FSH signaling may be affected in immature SCs lacking insulin/IGF signaling. Using qRT-PCR, we found in mutant purified SCs that transcript levels coding for the FSH receptor (FSHR) were reduced both at P5 and P15 by 26% and 37%, respectively ( Figure 6P ). In a similar manner, we found that inhibin B expression was also reduced in purified mutant SCs specifically at P0 and P5 ( Figure 6J ). In contrast, the expression of housekeeping genes as well as Amh was not affected, suggesting a specific alteration (data not shown). The reduced FSHR expression observed in mutant SCs should have a negative impact on FSH action and explain in part the incapacity of SCs lacking insulin/IGF signaling to proliferate after hemicastration or FSH treatment during the neonatal period.
Next we examined the expression and activation of protein kinase B/AKT, a signaling molecule that is part of the PI3K/AKT pathways known to be activated by both FSH and/or IGFs exposure in SCs and granulosa cells (48, 49) . In control testes, we found by IF that AKT and its phosphorylated form were present at high levels specifically at P5 in the center of the testis cords, a region that corresponds to the cytoplasm of SCs (Figure 6 , J-L). In contrast, we observed that immature SCs of mutant testes at P5 were almost devoid of AKT signal ( Figure 6 , M-O), suggesting that the PI3K/AKT signaling pathway is not functional in immature SCs around P5.
Discussion
The major objectives of this study were to investigate the potential roles of the insulin-like family of growth factors on testis development and spermatogenesis. By deleting Insr and/or Igf1r either in GCs or in SCs, we provide in vivo evidence that the insulin receptor family is dispensable in the GC lineage but plays a major role in regulating immature SC proliferation and maturation and ultimately the total pool of adult SCs. Compared with single receptor mutant mice, we observed a more severe reduction in total SC number and testis size in mice lacking both Insr and Igf1r, revealing a novel concerted action of both INSR and IGF1R in testicular development. In addition, both in vivo and in vitro analyses revealed that FSH requires the insulin/IGF signaling pathway to mediate its proliferative effects on immature SCs. Our data reinforce the view that the local production of insulin/IGF growth factors is the major intratesticular signal regulating SC number, testis size, and sperm output in mammals.
Although several factors play a role in the proliferation and maturation of SCs (50), insulin/IGF signaling is likely to represent the major hormonal signal involved in the establishment of a normal-sized cohort of SCs. When the influence of known factors affecting SC numbers such as FSH, androgens, or thyroid hormones are compared, our data indicate that the insulin signaling pathway is quantitatively the most important pathway regulating the final pool of SCs. In mice lacking the FSH receptor specifically in SCs (FSHRKO), the reduction in testis weight and SC number was approximately 55% to 60% (7) compared with Ͼ70% for SC-Insr;Igf1r mice. Similarly, transient neonatal hyperthyroidism resulted in a 50% reduction in the final SC number at P23 due to direct suppression of SC proliferation while their maturation is promoted (51) In contrast, androgens do not appear to have a direct effect on SC proliferation. Although androgens were initially shown to regulate SC proliferation in androgenresistant tfm mice (52), the pool of adult SCs was not affected in mice lacking the androgen receptor specifically in the SC (SCARKO) (7), indicating that the androgendependent regulation of SC number is an indirect effect of androgen on the SC.
Interconnected actions of both FSH and IGF1 in regulating SC proliferation and function
The insulin/IGF family of growth factors acts mainly through INSR and IGF1R and activates 2 major signaling pathways, namely the extracellular signal-regulated kinase/MAPK pathway and the PI3K/AKT pathway, both of which are important mediators of proliferation and cell survival. Although the FSHR belongs to the superfamily of G protein-coupled receptors, both the MAPK and PI3K/AKT pathways are also activated upon FSH binding to its receptor (for review, see 53) , suggesting that FSH and IGF actions may be intricately interconnected and coordinated in SCs.
First, it has been shown that FSH is capable of stimulating the secretion of IGF1 by immature SCs (54 -56) . In addition, FSH has been shown to amplify IGF1-mediated PI3K/AKT signaling in SCs. These results provide evidence that FSH interacts with the IGF pathways at different levels to stimulate the secretion of IGF1 by SCs and also enhances its effects on PI3K/AKT signaling (48) . Our in vivo results demonstrate that both INSR and IGF1R are required for FSH-mediated SC proliferation. However, the precise mechanism explaining how the insulin/ IGF signaling pathway is required for FSH action in immature SCs is only starting to be unraveled. IGFs could act at several levels by stimulating either the expression of the FSHR and/or the activation of downstream signaling pathways common to both IGFs and FSH. Our expression analysis revealed first that Fshr transcripts were reduced in purified SCs lacking insulin/IGF signaling but only at P5 and P15 and not at earlier stages ( Figure 6P ). This reduction may affect FSH action and explain in part the incapacity of mutant SCs to proliferate after hemicastration or FSH treatment. Second, we also found that both INSR and IGF1R are required for AKT expression and activation in SCs at P5 (Figure 6 , J-O) suggesting that AKT mediates the synergistic effect of FSH and IGFs on SC proliferation. Similar interactions between the IGF system and FSH have been reported in granulosa cells. Fshr expression and mRNA stability are increased by IGF-1 treatment in rat granulosa cells (57) . In addition, it has been recently reported that IGFIR activity is essential for FSH-induced phosphorylation of AKT (49) . Rat granulosa cells treated with a IGF1R inhibitor abolished AKT activation by FSH and prevented expression of steroidogenic genes and estradiol production. Taken together, these results obtained in both granulosa cells and SCs suggest a crucial role for IGFs in mediating FSH action in the gonads.
Insulin/IGF signaling in SCs is not essential for spermatogenesis and sperm production
The major role of SCs in the adult testis is to support GCs and secrete factors that control the survival and progression of GCs through the sequential steps of spermatogenesis. Based on in vitro studies suggesting that IGF1 regulates several functions of the mature SC (48, 58), we would have expected that ablation of insulin/IGF signaling in adult SCs or GCs would cause detrimental consequences for sperm production and mouse fertility. Surprisingly, this was not the case. First, ablation of both Insr and Igf1r in the GC lineage did not reveal alterations in sperm production and fertility (see Supplemental Figure  2 ). Second, although conditional deletion of Insr and Igf1r in SCs reduced drastically the final number of SCs by decreasing the survival rate and delaying differentiation of immature SCs, the capacity of adult SCs to support spermatogenesis is only mildly affected. A precise assessment of spermatogenesis in SC-Insr;Igf1r mutant mice at P60 revealed a small but significant decrease in the efficiency of sperm production. Using flow cytometry of PIlabeled cells to evaluate the abundance of haploid (1n; spermatids and spermatozoa), diploid (2n; spermatogonia A and B), and tetraploid cells (4n; spermatocytes I) in P60 adult animals, we found a decrease in the proportion of haploid cells in SC-Insr;Igf1r mutant testes (Supplemental Figure 6 , A-C). Interestingly, the expression of some Sertoli-specific genes such as inhibin ␣ and Steel (KitL) was significantly higher in SC-Insr;Igf1r testes, whereas other transcripts coding for Amh, Gata1, transferrin, Pem, and testin were not affected (Supplemental Figure 6D) . Because inhibin is known to be stimulated by FSH, we also assessed gonadotropin and androgen levels in SC-Insr;Igf1r mutant mice. Although plasma levels of LH and activin were unaffected, we observed a significant 2.5-fold increase in FSH levels of SC-Insr;Igf1r mutant mice ( Figure 5 , G-J). Importantly, we observed significant 7.7-and 3-fold increase in testosterone levels of control and SC-Insr;Igf1r mutant mice after hCG stimulation, indicating normal although blunted androgen production by Leydig cells. These findings indicate that growth factors of the insulin family are key to regulating the final number of SCs and testis size but dispensable for SCs to support the spermatogenic process.
Receptor contribution
Comparative analysis of mutant animals lacking Insr, Igf1r, or both Insr and Igf1r in SCs provided information concerning the relative degree of contribution and functional redundancy of each receptor in regulating SC number and testis size. Testes lacking Insr or Igf1r in SCs displayed weight reductions of 13.6% and 34.6%, respectively, indicating that the contribution of IGF1R is more important than INSR. In addition, the concomitant ablation of both receptors resulted in a much more severe reduction in testis weight (72.4%), implying an important redundancy and suggesting that INSR and IGF1R act in a synergistic manner to regulate SC number and testis size.
Taking into account both the ligand-binding affinities and the relative contribution of INSR and IGF1R to the phenotype, we can obtain some important information concerning the identity of the potential ligand(s) mediating SC survival in the developing testis. The affinity of insulin for IGF1R has been reported to be 500 to 1000 times lower than that of the IGFs (59) . IGF2 binds to its cognate receptor (IGF1R) and also to one of the insulin receptor isoforms (IR-A), exhibiting an affinity that is ϳ30% that of insulin (21, 60) . Finally, IGF1 binds IGF1R with up to 20-fold higher affinity than IGF2 (61) . The robust expression of IGF1 and IGF2 in spermatogonia (see Figure 1 and Supplemental Figure 1 ) raises the hypothesis that GCs themselves may finely regulate the number of SCs and thus testis size and daily sperm output, through the secretion of growth factors promoting SC survival and maturation during postnatal testicular development. Clearly further investigations are required to test this hypothesis.
